ORIC PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $27.9M | $252.0M | $23.4M |
| FY2024 | $31.0M | $274.1M | $59.4M |
| FY2025 | $24.5M | $408.9M | $45.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $27.9M | $252.0M | $23.4M |
| FY2024 | $31.0M | $274.1M | $59.4M |
| FY2025 | $24.5M | $408.9M | $45.7M |